Live News EQUITY L impact Jun 23, 2026, 08:57 PM UTC

TPST: CEO Buys Shares

Tempest Therapeutics CEO and President Angel Matthew P buys 231,482 shares at $2.16

SQUAWKNEWS Updated Jun 23, 2026, 08:57 PM UTC

FORM 4P - TPST - Tempest Therapeutics, Inc.* DIRECTOR|OFFICER|10% OWNER|OTHER - CEO and President: Angel Matthew P | 231,482 | $2.16 | $500,001